Cervical cancer remains a devastating reality for countless Malian women. Take the case of Fatoumata, a 38-year-old mother who became one of its victims.

« I first had a fibroid treated, but it took time. It was when I started experiencing bleeding that I opted for surgery. After the operation, I noticed unusual discharges—watery, odorless. That prompted me to visit my gynecologist. The tests revealed cervical cancer. The treatment cost me between 5 and 6 million West African CFA francs, with the surgery alone accounting for two million. »

This initiative aims to shield over 320,000 Malian girls annually, potentially reducing cervical cancer cases by nearly 90% and preventing more than 3,600 deaths each year.

Fatoumata’s story highlights the harsh realities faced by many Malian women: late diagnosis, exorbitant treatment costs, and limited access to quality healthcare. Cultural barriers further complicate the situation, with myths and misconceptions often delaying medical intervention.

The burden of cervical cancer in Mali

Cervical cancer, primarily caused by persistent HPV infection, is a critical public health challenge in Mali. It ranks as the second most common cancer among women aged 15 to 44. Tragically, many cases are detected too late, leading to preventable deaths. Cultural taboos often prevent women from openly discussing symptoms, with some attributing the disease to curses or spells from rivals.

« Cervical cancer is sometimes perceived as a curse cast by a co-wife, sister-in-law, or former partner, » explains a reproductive health advocate. This stigma delays diagnosis and exacerbates the consequences of the disease.

A landmark achievement: the introduction of the HPV vaccine

In a historic move, Mali has become one of the first Sahelian nations—and the first conflict-affected country supported by Gavi—to introduce the HPV vaccine into its routine immunization schedule. Dr. Ibrahima Diarra, Director of Mali’s National Immunization Center, emphasized the significance of this milestone: « A single dose can protect a 10-year-old girl for over a decade against the HPV strains responsible for 70% of cervical cancers. » Thanks to Gavi’s support and co-financing from the Malian government, the vaccine is now provided free of charge to young girls.

This initiative aims to shield over 320,000 Malian girls annually, potentially reducing cervical cancer cases by nearly 90% and preventing more than 3,600 deaths each year. The choice to vaccinate girls at age 10 aligns with WHO recommendations, as their cervixes are still healthy before the onset of sexual activity, ensuring maximum vaccine efficacy.

Advancing health equity

This vaccination program marks a significant stride toward health equity. Cervical cancer disproportionately affects women in low-income countries, where 90% of the 348,000 global deaths in 2022 occurred. By making prevention accessible to all girls, regardless of whether they live in urban or rural areas, Mali is taking a bold step toward justice in healthcare.

Dr. Diarra explains the rationale behind targeting 10-year-old girls: « We selected this age group because their cervixes are still healthy, ensuring optimal vaccine effectiveness before sexual activity begins. » This approach is in line with the World Health Organization’s (WHO) guidelines, which prioritize vaccination for girls aged 9 to 14.

Mali stands out as a pioneer among Sahelian nations and the first conflict-affected country supported by Gavi to introduce the HPV vaccine.

Besides saving lives, the HPV vaccine reduces the financial burden of treating advanced-stage cervical cancer. « A single dose costs around 150,000 West African CFA francs in private pharmacies, » notes Dr. Diarra. « Thanks to Gavi’s support and government co-financing, the vaccine is now free as part of the routine immunization program. »

This initiative not only safeguards future generations of Malian women but also sets a powerful example for other countries in the region. It aligns with Gavi’s global objectives to vaccinate 86 million girls in low- and middle-income countries by 2025.

Combating misinformation

Mali’s health authorities face another hurdle: misinformation. False claims and rumors about vaccines occasionally circulate, fueled by opponents. « It’s crucial to counter these inaccuracies, » insists Dr. Diarra. « This vaccine is safe, effective, and does not compromise fertility or reproductive health. » Health Minister Colonel Assa Badiallo Touré echoed this sentiment during the launch.

The introduction of the HPV vaccine represents a monumental victory for women’s health in Mali. By breaking the cycle of disease through prevention, the country is pioneering a public health model centered on equity—one that protects the most vulnerable and paves the way for a healthier, more secure future for Malian women.